{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T08:28:19Z","timestamp":1782289699977,"version":"3.54.5"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T00:00:00Z","timestamp":1722038400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015285","name":"Hebei Province Medical Science Research Key Project","doi-asserted-by":"publisher","award":["2021281"],"award-info":[{"award-number":["2021281"]}],"id":[{"id":"10.13039\/501100015285","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jneuroim.2024.578410","type":"journal-article","created":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T23:57:00Z","timestamp":1721779020000},"page":"578410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A case report of lymphoproliferative disease in brain following therapies with mycophenolate Mofetil and Fingolimod and literature review"],"prefix":"10.1016","volume":"394","author":[{"given":"Ge","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhi","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2024.578410_bb0005","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.mehy.2015.11.029","article-title":"Hypothesis: Fingolimod explores new horizons in treatment of lymphoma [J]","volume":"86","author":"Azimi","year":"2016","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.jneuroim.2024.578410_bb0010","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.msard.2016.12.009","article-title":"Antecedent anti-NMDA receptor encephalitis in two patients with multiple sclerosis [J]","volume":"12","author":"Baheerathan","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"11","key":"10.1016\/j.jneuroim.2024.578410_bb0015","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1177\/0961203317691370","article-title":"Development of primary central nervous system lymphoma in a systemic lupus erythematosus patient after treatment with mycophenolate mofetil and review of the literature [J]","volume":"26","author":"Balci","year":"2017","journal-title":"Lupus"},{"issue":"6\u20137","key":"10.1016\/j.jneuroim.2024.578410_bb0020","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.annder.2018.02.010","article-title":"Primary cutaneous CD30+ T-cell lymphoproliferation during treatment with fingolimod: case report and literature review [J]","volume":"145","author":"Cesbron","year":"2018","journal-title":"Ann. Dermatol. Venereol."},{"issue":"1","key":"10.1016\/j.jneuroim.2024.578410_bb0025","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1186\/s12888-021-03351-7","article-title":"Anti-N-methyl-D-aspartate receptor encephalitis presenting as atypical psychosis in multiple sclerosis: a case report [J]","volume":"21","author":"Chahal","year":"2021","journal-title":"BMC Psychiatry"},{"issue":"2","key":"10.1016\/j.jneuroim.2024.578410_bb0030","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jbspin.2019.10.005","article-title":"Epstein-Barr virus-associated primary central nervous system lymphoma in a patient with diffuse cutaneous systemic sclerosis on long-term mycophenolate mofetil [J]","volume":"87","author":"Chatterjee","year":"2020","journal-title":"Joint Bone Spine"},{"issue":"6","key":"10.1016\/j.jneuroim.2024.578410_bb0035","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1111\/bjd.17003","article-title":"Primary cutaneous CD30(+) anaplastic large-cell lymphoma associated with fingolimod [J]","volume":"179","author":"Connolly","year":"2018","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"10.1016\/j.jneuroim.2024.578410_bb0040","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1001\/jamaneurol.2014.1817","article-title":"Severe cognitive impairment associated with intrathecal antibodies to the NR1 subunit of the N-methyl-D-aspartate receptor in a patient with multiple sclerosis [J]","volume":"72","author":"Fleischmann","year":"2015","journal-title":"JAMA Neurol."},{"issue":"6","key":"10.1016\/j.jneuroim.2024.578410_bb0045","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/NEN.0000000000000076","article-title":"CNS lymphoma: a practical diagnostic approach [J]","volume":"73","author":"Giannini","year":"2014","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2024.578410_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102075","article-title":"Co-existence of multiple sclerosis and anti-NMDA receptor encephalitis: a case report and review of literature [J]","volume":"42","author":"Gulec","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jneuroim.2024.578410_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.595417","article-title":"Case report: overlapping multiple sclerosis with anti-N-methyl-D-aspartate receptor encephalitis: a case report and review of literature [J]","volume":"11","author":"Huang","year":"2020","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.jneuroim.2024.578410_bb0060","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1136\/jnnp.2010.226340.155","article-title":"POI14\u00a0multiple sclerosis: a potential association with anti-N-methyl-d-aspartate receptor encephalitis [J]","volume":"81","author":"Johnston","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.jneuroim.2024.578410_bb0065","doi-asserted-by":"crossref","DOI":"10.1136\/bmjno-2020-000096","article-title":"Bortezomib for anti-NMDAR encephalitis following daclizumab treatment in a patient with multiple sclerosis [J]","volume":"3","author":"Karunaratne","year":"2021","journal-title":"BMJ Neurol Open"},{"key":"10.1016\/j.jneuroim.2024.578410_bb0070","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2377-14-21","article-title":"Fingolimod (FTY720) therapy in Japanese patients with relapsing multiple sclerosis over 12 months: results of a phase 2 observational extension [J]","volume":"14","author":"Kira","year":"2014","journal-title":"BMC Neurol."},{"issue":"12","key":"10.1016\/j.jneuroim.2024.578410_bb0075","article-title":"Primary central nervous system lymphoma presenting as multifocal brain abscesses [J]","volume":"12","author":"Liang","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.jneuroim.2024.578410_bb0080","doi-asserted-by":"crossref","first-page":"1088801","DOI":"10.3389\/fimmu.2023.1088801","article-title":"Overlapping anti-NMDAR encephalitis and multiple sclerosis: a case report and literature review [J]","volume":"14","author":"Liu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2024.578410_bb0085","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.expneurol.2015.10.006","article-title":"The molecular physiology of the axo-myelinic synapse [J]","volume":"276","author":"Micu","year":"2016","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.jneuroim.2024.578410_bb0090","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10072-022-06367-3","article-title":"Primary central nervous system lymphoma in a patient with multiple sclerosis using fingolimod [J]","volume":"44","author":"Morillos","year":"2023","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2024.578410_bb0095","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jocn.2017.10.077","article-title":"Mycosis fungoides - a cutaneous lymphoproliferative disorder in a patient treated with fingolimod for multiple sclerosis [J]","volume":"48","author":"Nitsan","year":"2018","journal-title":"J. Clin. Neurosci."},{"issue":"5","key":"10.1016\/j.jneuroim.2024.578410_bb0100","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000141","article-title":"NMDA receptor antibodies: a rare association in inflammatory demyelinating diseases [J]","volume":"2","author":"Ramberger","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"10.1016\/j.jneuroim.2024.578410_bb0105","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.neuron.2016.05.016","article-title":"Oligodendroglial NMDA receptors regulate glucose import and axonal energy metabolism [J]","volume":"91","author":"Saab","year":"2016","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.jneuroim.2024.578410_bb0110","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/mrcr\/rxab012","article-title":"Primary central nervous system lymphoma in a patient with neuropsychiatric systemic lupus erythematosus receiving mycophenolate mofetil: a case report and literature review [J]","volume":"6","author":"Sakairi","year":"2022","journal-title":"Mod Rheumatol Case Rep"},{"issue":"9","key":"10.1016\/j.jneuroim.2024.578410_bb0115","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1007\/s10072-021-05385-x","article-title":"Anti-N-methyl-D-aspartate receptor encephalitis in a patient with multiple sclerosis on dimethyl fumarate: a case report [J]","volume":"42","author":"Seyed Ahadi","year":"2021","journal-title":"Neurol. Sci."},{"issue":"6","key":"10.1016\/j.jneuroim.2024.578410_bb0120","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1080\/20009666.2020.1811066","article-title":"Eosinophilic granulomatosis with polyangiitis (EGPA) on remission with a new neuropathy: a rare case of mycophenolate induced primary CNS lymphoproliferative disease [J]","volume":"10","author":"Shrestha","year":"2020","journal-title":"J. Community Hosp. Intern. Med. Perspect."},{"key":"10.1016\/j.jneuroim.2024.578410_bb0125","first-page":"bcr","article-title":"NMDAR (N-methyl-D-aspartate receptor) encephalitis in a patient with MS (multiple sclerosis): a rare and challenging case [J]","volume":"2018","author":"Suleman","year":"2018","journal-title":"BMJ Case Rep."},{"issue":"12","key":"10.1016\/j.jneuroim.2024.578410_bb0130","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.5692\/clinicalneurol.54.1107","article-title":"Autoimmune encephalitis-update: roles of autoantibodies in the pathogenesis [J]","volume":"54","author":"Tanaka","year":"2014","journal-title":"Rinsho Shinkeigaku"},{"issue":"1","key":"10.1016\/j.jneuroim.2024.578410_bb0135","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10072-020-04729-3","article-title":"Long-term persistence of NMDAR antibodies after encephalitis with de novo occurrence of demyelinating disorder [J]","volume":"42","author":"Tappat\u00e0","year":"2021","journal-title":"Neurol. Sci."},{"issue":"2","key":"10.1016\/j.jneuroim.2024.578410_bb0140","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria [J]","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.jneuroim.2024.578410_bb0145","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.clineuro.2011.10.047","article-title":"Anti-N-methyl D-aspartate-type glutamate receptor antibody-positive limbic encephalitis in a patient with multiple sclerosis [J]","volume":"114","author":"Uzawa","year":"2012","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.jneuroim.2024.578410_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-0500-7-948","article-title":"Demyelinating disease and anti-N-methyl-D-aspartate receptor immunoglobulin G antibodies: a case report [J]","volume":"7","author":"Waschbisch","year":"2014","journal-title":"BMC. Res. Notes"},{"issue":"5","key":"10.1016\/j.jneuroim.2024.578410_bb0155","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/bies.20402","article-title":"NMDA receptors expressed in oligodendrocytes [J]","volume":"28","author":"Wong","year":"2006","journal-title":"Bioessays"},{"key":"10.1016\/j.jneuroim.2024.578410_bb0160","article-title":"Case report: antibodies to the N-methyl-D-aspartate receptor in a patient with multiple sclerosis [J]","volume":"12","author":"Zhou","year":"2021","journal-title":"Front. Immunol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572824001292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572824001292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T04:02:00Z","timestamp":1724731320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572824001292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":32,"alternative-id":["S0165572824001292"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2024.578410","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A case report of lymphoproliferative disease in brain following therapies with mycophenolate Mofetil and Fingolimod and literature review","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2024.578410","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"578410"}}